New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
IQVIA Holdings Inc.
IQV
Shape
US Flag

NYSE

39B

Medical - Diagnostics & Research

Next Earning date - 31 Oct 2024

39B

Medical - Diagnostics & Research

Next Earning date - 31 Oct 2024

214.63USD
Shape2.92 ( 1.38%)
favorite-chart

Relative Strenght

27
favorite-chart

Volume Buzz

-1%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

18%

Quote Panel

Shape
Updated October 27, 2024
1W -7.16 % 1M -9.43 % 3M -9.53 % 1Y 21.15 %

Key Metrics

Shape
  • Market Cap

    39.13B


  • Shares Outstanding

    182.30M


  • Share in Float

    180.80M


  • Dividende

    0


  • Earning Date

    31 Oct 2024


  • Price Target

    214.63


  • Average Volume

    1.02M


  • Beta

    1.494


  • Range

    167.42-261.73


  • Industry

    Medical - Diagnostics & Research


  • Website

    https://www.iqvia.com


  • Sector

    Healthcare


Fundamentals

Shape

20.42x

P/E Ratio

2.57x

P/S Ratio

5.82x

P/B Ratio

2.0

Debt/Equity

9.4%

Net Margin

$7.7

EPS

How IQV compares to sector?

P/E Ratio

Relative Strength

Shape

IQV

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$16B

Shape332%

2025-Revenue

$8.79

Shape342%

2025-EPS

$3B

Shape303%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

RBC Capital

initialise

Previous: Outperform

2024-09-04

Now: Underperform

RBC Capital

initialise

Previous: Not converted

2024-09-03

Now: Outperform

Jefferies

downgrade

Previous: Not converted

2024-07-24

Now: Hold

Goldman Sachs

initialise

Previous: Not converted

2024-06-06

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+14%

2.48
vs 2.17

Q4.22

arrow
arrow

+9%

2.78
vs 2.55

Q1.23

arrow
arrow

-1%

2.45
vs 2.47

Q2.23

arrow
arrow

0%

2.43
vs 2.44

Q3.23

arrow
arrow

+0%

2.49
vs 2.48

Q4.23

arrow
arrow

+2%

2.84
vs 2.78

Q1.24

arrow
arrow

+4%

2.54
vs 2.45

Q2.24

arrow
arrow

+9%

2.64
vs 2.43

Q3.24

arrow
arrow

+13%

2.81
vs 2.49

Q4.24

arrow
arrow

+13%

3.21
vs 2.84

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+5%

3.6B  vs 3.4B

Q4.22

arrow
arrow

+3%

3.7B  vs 3.6B

Q1.23

arrow
arrow

+2%

3.7B  vs 3.6B

Q2.23

arrow
arrow

+5%

3.7B  vs 3.5B

Q3.23

arrow
arrow

+5%

3.7B  vs 3.6B

Q4.23

arrow
arrow

+5%

3.9B  vs 3.7B

Q1.24

arrow
arrow

+2%

3.7B  vs 3.7B

Q2.24

arrow
arrow

+2%

3.8B  vs 3.7B

Q3.24

arrow
arrow

+3%

3.9B  vs 3.7B

Q4.24

arrow
arrow

+4%

4.1B  vs 3.9B

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+5%

0.05
vs 0.05

Q4.22

arrow
arrow

+4%

0.04
vs 0.05

Q1.23

arrow
arrow

+5%

0.05
vs 0.04

Q2.23

arrow
arrow

+5%

0.05
vs 0.05

Q3.23

arrow
arrow

+5%

0.05
vs 0.05

Q4.23

arrow
arrow

+8%

0.08
vs 0.05

Q1.24

arrow
arrow

+5%

0.05
vs 0.08

Q2.24

arrow
arrow

+5%

0.05
vs 0.05

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

892

892
vs 884

1%

Q4.22

arrow
arrow

929

929
vs 892

4%

Q1.23

arrow
arrow

936

936
vs 929

1%

Q2.23

arrow
arrow

941

941
vs 936

1%

Q3.23

arrow
arrow

953

953
vs 941

1%

Q4.23

arrow
arrow

968

968
vs 953

2%

Q1.24

arrow
arrow

1026

1K
vs 968

6%

Q2.24

arrow
arrow

1012

1K
vs 1K

-1%

Earnings Growth

Latest News